Landspítali

KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO

Retrieved on: 
Tuesday, April 2, 2024

RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC's aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga's notable career and proven track record of leadership in top-tier medical institutions.

Key Points: 
  • RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024.
  • His administration at Karolinska was marked by innovative strategies and excellence in healthcare delivery—all which he is posed to enrich within KFSH&RC.
  • Dr. Zoégabrings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center.
  • As Deputy CEO, Dr. Zoéga will serve as chief lead of KFSH&RC’s healthcare delivery and research and innovation groups, following on the hospital’s commitment to integrating global best practices in healthcare and pursuing cutting-edge medical research and technology.

Hemcheck has received a first order from a leading hospital in Iceland

Retrieved on: 
Tuesday, January 24, 2023

SOLNA, Sweden, Jan. 24, 2023 /PRNewswire/ -- Hemcheck has received a first order from Landspitali, the leading university hospital in Iceland.

Key Points: 
  • SOLNA, Sweden, Jan. 24, 2023 /PRNewswire/ -- Hemcheck has received a first order from Landspitali, the leading university hospital in Iceland.
  • The order is a first test order regarding both v-Test and bgs-Test and is of lower economic value.
  • - It is very positive news that we have received this first order from Landspitali.
  • It is a reputable hospital and we hope for more orders from them, says Joen Averstad, CEO of Hemcheck.